Blake Schroeder - Feb 10, 2022 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Director
Signature
/s/ Blake Neil Schroeder
Stock symbol
AXIM
Transactions as of
Feb 10, 2022
Transactions value $
$625,000,000
Form type
4
Date filed
2/15/2022, 05:04 PM
Next filing
Aug 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note (Convertible into Common Stock) Other $625M +25K +8.84% $25,000.00* 308K Feb 10, 2022 Common Stock 308K $0.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Note bears interest at a rate of 3% per annum. At the election of the Reporting Person, all principal and accrued interest under the Note may be converted into the Issuer's common stock at a converstion price equal to the lesser of $0.08125 or 70% of the average of the two lowest closing prices of the Issuer's common stock in the ten (10) days prior to the date of conversion.